Patents Assigned to Universidad de Caldas
  • Patent number: 11197893
    Abstract: A pure platelet-rich plasma (P-PRP) composition as an alternative to conventional antibiotic treatment of subclinical mastitis caused by Gram-positive bacteria in bovine including five live platelets and leukocytes, an anticoagulant, and an activating substance.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: December 14, 2021
    Assignee: Universidad de Caldas
    Inventors: Alejandro Ceballos, Jorge U. Carmona
  • Patent number: 9556409
    Abstract: Fixed bed bioreactor with natural convection and forced draught to obtain bioactive substances by solid-state fermentation (SEF) using fungi macromycetes. This bioreactor may be from turn drum with pendulum motion and natural and forced convection to a tray bioreactor with natural convection. They are used in the production of bioactive substances as crude extracts of lignocellulosic enzymes and fungal polysaccharides obtained by using mixtures of lignocellulosic materials as substrates and macromycetes fungi as inoculum, controlling pH, humidity and particle size, inoculation rate and environmental conditions during fermentation such as temperature, relative humidity and carbon dioxide and oxygen concentration.
    Type: Grant
    Filed: April 17, 2013
    Date of Patent: January 31, 2017
    Assignee: Universidad de Caldas
    Inventors: Sandra Montoya-Barreto, Oscar Julian Sanchez-Toro, Luis Fernando Gutierrez Mosquera
  • Patent number: 9145352
    Abstract: The use of quaternary halogenated ammonium salts for treating leishmaniasis infections and other parasitic diseases is described. Although there have been previous reports in which quaternary ammonium salts are used as antimalarial, antifungal, and antileishmanial compounds, the use of such salts containing a halogenated N-methyl substituent as a therapeutic agent against leishmaniasis had not been reported. The compounds described here, in specific those with a terminal arylalkenyl or diarylalkenyl moiety, are shown to inhibit the growth of Leishmania panamensis parasites, a known causative agent of leishmaniasis disease. In addition, the series of compounds are also extensive against malaria, Chagas disease, toxoplasmosis, and other parasitic diseases.
    Type: Grant
    Filed: May 30, 2012
    Date of Patent: September 29, 2015
    Assignees: UNIVERSIDAD DE CALDAS, UNIVERSIDAD DE ANTIOQUIA, THE BOARD OF TRUSTEES OF ILLINOIS STATE UNIVERSITY
    Inventors: Luz Amalia Rios Vasquez, Rogelio Ocampo Cardona, Sandra Milena Duque, Sara Maria Robledo Restrepo, Ivan Dario Velez Bernal, David Leonardo CedeƱo Medina, Marjorie Ann Jones
  • Publication number: 20150197718
    Abstract: Fixed bed bioreactor with natural convection and forced draught to obtain bioactive substances by solid-state fermentation (SEF) using fungi macromycetes. This bioreactor may be from turn drum with pendulum motion and natural and forced convection to a tray bioreactor with natural convection. They are used in the production of bioactive substances as crude extracts of lignocellulosic enzymes and fungal polysaccharides obtained by using mixtures of lignocellulosic materials as substrates and macromycetes fungi as inoculum, controlling pH, humidity and particle size, inoculation rate and environmental conditions during fermentation such as temperature, relative humidity and carbon dioxide and oxygen concentration.
    Type: Application
    Filed: April 17, 2013
    Publication date: July 16, 2015
    Applicant: Universidad de Caldas
    Inventor: Universidad de Caldas